Trinity Biotech plc (NASDAQ:TRIB) headquartered in Bray, will host a conference call for the investment community to discuss the 2Q20 earnings result on 25th August 2020 at 11:00 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit 78449.choruscall.com/dataconf/productusers/trib/mediaframe/40218/indexr.html
Individuals interested in participating in the audio call may dial the listen only number(s) 1-844-861-5499 Toll Free, (United States) or 1-412-317-6581 (International)
Earnings Expectation
Trinity Biotech plc is reporting second quarter financial results on Tuesday 25th August 2020, before market open.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease, sexually transmitted diseases, respiratory infections, epstein barr virus, and other viral pathogens; and products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a high risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia.
